Investors

Insider Transactions

Date Name Title Sorted Ascending Type Shares Traded Price Range
Jun 23, 2009 vagelos p roy Director Disposition (Non Open Market) 50,384 n/a
Jun 13, 2008 vagelos p roy Director Disposition (Non Open Market) 115,082 n/a
Jul 9, 2008 vagelos p roy Director Disposition (Non Open Market) 8,105 n/a
Jul 10, 2008 vagelos p roy Director Disposition (Non Open Market) 30,705 n/a
Aug 4, 2008 vagelos p roy Director Disposition (Non Open Market) 114,309 n/a
Aug 4, 2008 vagelos p roy Director Acquisition (Non Open Market) 114,309 n/a
Aug 28, 2008 vagelos p roy Director Disposition (Non Open Market) 8,106 n/a
Oct 1, 2007 vagelos p roy Director Automatic Sell 11,560 n/a
Nov 20, 2007 vagelos p roy Director Automatic Sell 138,737 n/a
Jan 3, 2008 vagelos p roy Director Automatic Sell 8,658 n/a
Feb 27, 2008 vagelos p roy Director Option Execute 6,666 7.91
Mar 29, 2008 vagelos p roy Director Disposition (Non Open Market) 10,669 n/a
Jun 13, 2008 vagelos p roy Director Acquisition (Non Open Market) 115,082 n/a
Mar 22, 2010 aberman michael s Officer Acquisition (Non Open Market) 10,000 n/a
Sep 2, 2011 aberman michael s Officer Automatic Sell 4,166 64.00
Sep 2, 2011 aberman michael s Officer Option Execute 4,166 24.00
Sep 6, 2011 aberman michael s Officer Automatic Sell 4,957 65.76
Sep 6, 2011 aberman michael s Officer Option Execute 8,334 24.00
Sep 7, 2011 aberman michael s Officer Automatic Sell 3,377 67.39 - 70.39
Feb 18, 2014 aberman michael s Officer Automatic Sell 3,648 324.81 - 334.24
Showing 341-360 of 840 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)